unnecessary among "healthy women" and previous birth of a healthy baby without treatment. In contrast, facilitating factors for adherence were women's belief that they owe it to the baby, a positive relationship with the physician, knowing others who have successfully using antiretroviral therapy during pregnancy and previous experience of using it themselves during pregnancy
Further limitations in the scaling-up of antiretroviral therapy for PMTCT may include lack of availability of medication within the health care system and insufficient coverage regardless of availability of medication, due to the fact that many women deliver at home or no HIV test or intrapartum treatment is offered.
Another issue to be addressed is the establishment of health care priorities in an environment of poverty, low education, violence, overall lack of resources, inadequate infrastructure and high prevalence of life-threatening endemic diseases In a Ugandan survey of people living with HIV, people from the general population, health planners, health workers and people with hyper tension, nevirapine use for PMTCT ranked as number five in terms of health care priorities, as compared to treatment for eight other conditions, including treatment for childhood dis- eases (diarrhoea, pneumonia and malaria) and HAART for people living with HIV. Among these, HAART was ranked number one